I Agree

We have updated our Privacy and Cookie Policy. By clicking "I Agree" below, you acknowledge that you accept our Privacy and Cookie Policy and Terms of Use.

PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: MEREO BIOPH ORD GBP0.003 MPH Announcements

MEREO BIOPH ORD GBP0.003 (MPH) Announcements

Date Time Source Announcement
14 Jan 2020 12:00 pm
RNS
Additional positive data from phase 2b study
13 Jan 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  12:00 pm
RNS
Mereo and Oncologie Global Licensing Agreement
06 Jan 2020 4:45 pm
RNS
Holding(s) in Company
02 Jan 2020 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
31 Dec 2019 11:00 am
RNS
Price Monitoring Extension
27 Dec 2019 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
18 Dec 2019 2:22 pm
RNS
Notification of Major Holdings in Company
16 Dec 2019 2:17 pm
RNS
Notification of Holdings in Company
  2:17 pm
RNS
Notification of Holdings in Company
03 Dec 2019 4:54 pm
RNS
PDMR Shareholding
27 Nov 2019 4:12 pm
RNS
Director Shareholding
25 Nov 2019 5:02 pm
RNS
Director Shareholding
22 Nov 2019 5:09 pm
RNS
Director/PDMR Shareholding
20 Nov 2019 2:31 pm
RNS
PDMR Shareholding
11 Nov 2019 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Mereo BioPharma Phase 2b ASTEROID Study
18 Oct 2019 7:00 am
RNS
Holdings in Company
17 Oct 2019 2:20 pm
RNS
Holdings in Company
14 Oct 2019 12:21 pm
RNS
Notification of Director Dealing
07 Oct 2019 1:00 pm
RNS
FDA Fast Track Designation for Navicixizumab
04 Oct 2019 2:57 pm
RNS
PDMR Notification
02 Oct 2019 3:54 pm
RNS
PDMR Notification
26 Sep 2019 12:04 pm
RNS
PDMR Dealing
25 Sep 2019 10:38 am
RNS
PDMR Dealing
24 Sep 2019 1:00 pm
RNS
Director Dealing
20 Sep 2019 2:22 pm
RNS
Director Shareholding
17 Sep 2019 7:00 am
RNS
Interim results for 6 months ended June 30, 2019
13 Sep 2019 3:30 pm
RNS
Directors' details update
10 Sep 2019 1:00 pm
RNS
Notice of Results
06 Sep 2019 7:00 am
RNS
Block listing Interim Review
04 Sep 2019 1:00 pm
RNS
Mereo announces phase 2b data at ASBMR Meeting
16 Aug 2019 1:51 pm
RNS
Director/PDMR Shareholding
15 Aug 2019 4:59 pm
RNS
PDMR Shareholding
12 Aug 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
09 Aug 2019 4:35 pm
RNS
Price Monitoring Extension
31 Jul 2019 12:51 pm
RNS
Director Declaration
25 Jul 2019 4:56 pm
RNS
PDMR Shareholding
24 Jul 2019 10:08 am
RNS
Director/PDMR Shareholding
19 Jul 2019 1:21 pm
RNS
Director/PDMR Shareholding
16 Jul 2019 1:00 pm
RNS
Appointment of Richard Francis
15 Jul 2019 1:00 pm
RNS
Successful Type B Meeting with U.S. FDA
08 Jul 2019 3:54 pm
RNS
Holding(s) in Company
03 Jul 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
27 Jun 2019 3:33 pm
RNS
Holding(s) in Company
  3:33 pm
RNS
Holding(s) in Company
26 Jun 2019 4:36 pm
RNS
Holding(s) in Company
21 Jun 2019 1:00 pm
RNS
Conversion of loan note and issue of equity
20 Jun 2019 7:00 am
RNS
Result of AGM
13 Jun 2019 1:00 pm
RNS
Update on Etigilimab (TIGIT) Partnership
30 May 2019 7:00 am
RNS
Positive early 6 month data
23 May 2019 4:11 pm
RNS
Director/PDMR Shareholding
22 May 2019 9:45 am
RNS
PDMR Shareholding
21 May 2019 3:08 pm
RNS
Director/PDMR Shareholding
Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close